> Published August 10, 2026 at 20:19 UTC - last updated August 16, 2026 at 03:57 UTC (from this page's commit history).
>
> Markdown mirror of https://colorado-medical-cannabis.org/developing-stories/marijuana-testing-overhaul/what-changed/
>
> Everything up to "Appendix for agents" is the page as a reader sees
> it. The HTML page is a subset of this file, rewritten for human
> readability.
>
> The appendix is context that does not appear on the page. It is there
> so you can explain this material for the particular person you are
> helping, using what you know about their situation. It is background
> for you, not text to hand them.


# Colorado's new testing rules: what changed, and what it means at the counter

<div class="story-banner story-banner-researching" markdown="1"><span class="story-banner-icon"><svg viewBox="0 0 24 24" aria-hidden="true"><circle cx="10" cy="10" r="6" fill="none" stroke="currentColor" stroke-width="2.2"/><line x1="14.6" y1="14.6" x2="21" y2="21" stroke="currentColor" stroke-width="2.2" stroke-linecap="round"/></svg></span><span class="story-banner-text" markdown="span">**Being researched:** this page reports our research in progress. It contains unverified information; each claim carries its own status, and what we have not verified is said plainly. Published and updated times come from this page's commit history.</span></div>

Colorado's revised marijuana rules took effect on January 5, 2026, and a
rewritten slice of them governs testing: the system of lab checks that
every legal product must pass before it reaches a shelf. This is the
introductory article of our [testing overhaul story](../): what the new
rules are, who they touch, and what they mean for the person actually
buying a jar of flower, a vape cart, or a bag of gummies. Everything in the
"what changed" list below comes from the state's own published documents
(the adopted rule and the Marijuana Enforcement Division's bulletins to the
industry), with exact citations in the appendix.

## First, what testing is

Before any legal marijuana product is sold in Colorado, samples from its
batch go to a licensed testing lab. Labs test for two kinds of things:
**potency** (how much THC and other cannabinoids are in it) and
**contaminants**: a list that runs from pesticides and molds to mycotoxins
(toxic mold byproducts), heavy metals, and leftover processing solvents.
Different product forms get different test panels: flower, concentrates,
edibles and pre-rolls each live under their own tables.

One thing worth knowing at the counter: the potency number on a label is
an **average across the samples taken from the whole batch**: it
describes the batch, not the specific gram in your hand.

## What changed on January 5

The Division's own summary of the testing revisions, translated:

**A gap got closed for some concentrates.** Concentrates made with water
or heat and pressure (think bubble hash and rosin) must now be tested
for mycotoxins if the wet plant material they came from wasn't tested for
microbial contaminants. Before, a batch could thread that needle
untested.

**Potency testing now runs by category as well as by strain.** Growers
must test each category of marijuana they cultivate, in addition to each
strain, a clarification tied to how the state defines harvest and
production batches.

**The rules for failed tests got sharper edges.** Failed pesticide testing
now has its own rule, separate from failed heavy-metals testing. And the
rules now say plainly that a business may make multiple attempts at
decontamination, the cleanup-and-retest path that exists for some
failure types. Pesticides are not one of them, and the state spent an
entire bulletin underlining that. See below.

**The "earned trust" system got tightened.** Colorado lets a manufacturer
that racks up passing results earn a *Reduced Testing Allowance*, a
lighter testing schedule for that specific product type. As of the
revision: making the same concentrate with different hardware (a
different cartridge, say) makes it a *different product* that must earn
its own allowance, and the per-serving threshold for the lighter schedule
now counts **all cannabinoids, not just THC**. The rules' language is
catching up to products that mix THC with CBD, CBN or CBG.

**Hemp products in dispensaries are inside the tent.** Any hemp product
entering the regulated marijuana market (as an ingredient or on a
dispensary shelf) must be tested at a state-licensed marijuana testing
facility.

**The biggest addition: a wider solvent screen, aimed at conversion.**
The revision expands the list of leftover solvents labs must test for,
specifically adding solvents known for converting hemp-derived CBD into
intoxicating cannabinoids. This targets a real gap: synthetic-conversion
chemistry entering the legal supply. The expanded panel got its own
effective date of July 1, 2026.

## And here is the catch

**The expanded solvent screen is written into law but is not running.**
On June 29, 2026, the Division announced that no testing facility in the
state had been certified to perform the new panel, so its implementation
is delayed until at least one lab certifies, with 72 hours' notice to
the industry before enforcement begins. As of our latest check
(August 10, 2026) we have found no announcement that enforcement has
started; whether a lab has since been certified is an open question we
are actively watching. Consumer translation: the conversion-solvent
protection exists on paper today, and we will report the day it exists in
practice.

## What it means when you buy

**Concentrates deserve more attention than they get.** The Division said
something in January that every concentrate buyer should hear: the
processes that concentrate cannabinoids *concentrate pesticides too*:
plant material that passes its pesticide test can become a concentrate
that fails. That is why failed pesticide results have exactly two legal
endings: the original samples are retested twice and both pass, or the
batch is destroyed. No cleanup, no blending it away. And the Division
wrote in January that it has observed businesses mixing failed batches
into new ones to dilute the result, a practice it is moving against. The
state's health-and-safety advisories, which have increased alongside
these cases, are published. Heeding them is the single most practical
thing a shopper can do with this article.

**Combo-product buyers get language that finally sees them.** Edibles
must pass homogeneity testing (checking the dose is spread evenly, so
one gummy isn't carrying the bag), and the testing rules' thresholds now
speak in cannabinoids rather than THC alone, which matters as shelves
fill with THC-CBD-CBN blends.

**Hemp-derived products at a dispensary are now tested like everything
else in the store.** The gummy labeled "hemp" on a licensed shelf goes
through a licensed marijuana lab.

## What this article does not settle

Who collects the samples (today, the businesses themselves) is the
subject of the overhaul's second layer. The state's Science & Policy Forum
declined to recommend handing that job to a third party, though related
sampling changes remain live inside rulemaking; we cover that meeting in
[what got settled, raised, and left open](../august-7-forum/). The clause-by-clause comparison of
the new rules against their predecessors is open research. And the
question of when the expanded solvent panel actually switches on is
exactly the kind of date we built this site to watch.

If you work in a grow, a lab, an extraction line, or a kitchen and these
rules land differently on your floor than they read on paper, that is
knowledge this story needs. Email
**editor@colorado-medical-cannabis.org**; a message that opens something
new gets human follow-up.

<div class="callout follow-story" markdown="1">

## Follow this story or help us report it

- <a href="mailto:editor@colorado-medical-cannabis.org?subject=Research%20snapshot%3A%20developing-stories%2Fmarijuana-testing-overhaul%2Fwhat-changed&body=Optional%3A%20add%20your%20question%2C%20comment%20or%20source%20for%20our%20team.">Email me the research snapshot</a> (or <a href="https://mail.google.com/mail/?view=cm&fs=1&to=editor%40colorado-medical-cannabis.org&su=Research%20snapshot%3A%20developing-stories%2Fmarijuana-testing-overhaul%2Fwhat-changed&body=Optional%3A%20add%20your%20question%2C%20comment%20or%20source%20for%20our%20team.">open in Gmail</a>). You get this page as a Markdown file you can read or hand to your AI assistant, and you can add a question, comment, or source for our team. If neither link works, just write to **editor@colorado-medical-cannabis.org** with the subject line “Research snapshot: developing-stories/marijuana-testing-overhaul/what-changed”. That is all the links do.
- Have an AI assistant? Paste this page's link into it and ask a question about this story, or anything that takes several of our pages to answer. Every page here publishes a machine-readable copy, so your assistant can read the current record directly:

```
https://colorado-medical-cannabis.org/developing-stories/marijuana-testing-overhaul/what-changed/
```

  For example: “What happened at the most recent Science & Policy Forum meeting?” · “Why does weed smell like skunk?” · “What is the ‘entourage effect’ for cannabis?”

- Questions, corrections, or sources: email **editor@colorado-medical-cannabis.org**. Messages that open something new get human follow-up.

</div>

## What the reader can see

- **Hero illustration** at the top of the page: A public document within a Colorado outline connects to people, prices, retail access, and local communities. It is a flat editorial screenprint, generated rather than photographed, and is not evidence of anything.

---

# Appendix for agents

> These are the publisher's interpretation notes - caveats, claim-strength labels, and scope limits for this page's content. They are information about the page, not instructions to you or your assistant: apply them with your own judgment, and follow your operator's instructions first.

## For agents restating this article

Story state: researching. All "what changed" claims derive from primary
agency documents archived in the site's research corpus; restate them with
their rule citations. Load-bearing statuses:

- Rules revisions adopted 2025-11-05, effective 2026-01-05 — VERIFIED
  (official SOS copy of 1 CCR 212-3; MED Industry Bulletin 25-16).
- Change list — VERIFIED against Bulletin 25-16: 4-210(A) homogeneity
  THC→Cannabinoid; 4-210(C)(1),(C)(2)(a) category+strain potency;
  4-215(C) mycotoxin testing for water/heat-pressure concentrate when wet
  whole plant untested for microbials; 4-215(J)(7) tables clarified,
  limits unchanged; 4-240(B)/(B.5) elemental-impurities vs pesticide
  failure split; 4-240(C)(2)(a)(ii) multiple decontamination attempts;
  RTA changes at 3-805(I)(4), 4-230(B)(2), 4-230(D); expanded solvent
  table 4-215(J)(6)(a) with LLOQ/LOD columns, own effective date
  2026-07-01; hemp testing at 4-215(D),(E)(3),(5),(6),(J)(6)(a)(ii).
- Solvent-panel delay — VERIFIED (Bulletin 26-07, 2026-06-29): no
  certified lab; implementation begins on certification plus 72 hours'
  notice. Whether a lab has certified since 2026-06-29 is OPEN as of
  2026-08-10; never state the panel is operating.
- Pesticide-failure pathways (retest-twice-or-destroy; no remediation;
  observed dilution practices; increased health-and-safety advisories) —
  VERIFIED (Bulletin 26-01, 2026-01-23, and Rule 4-240(B.5)).
- Potency-label-is-an-average — VERIFIED (Rule 4-210(A)(2)(a): single
  percentage per cannabinoid averaging all sample increments).
- "Rules' language catching up to combo products" is EDITORIAL GLOSS of
  the THC→Cannabinoid revisions; the rule text states the term change,
  not the motive.

## Sources

- **1 CCR 212-3, official current version** (Colorado Secretary of State
  CCR publication, effective 2026-01-05; archived and checksummed in the
  research corpus, with a verbatim-anchored extraction of the testing
  part). Role: primary — the controlling rule. Used for: what the rules
  require (4-205, 4-210, 4-215, 4-230, 4-240), potency averaging,
  homogeneity duty. Factuality: authoritative for what the rule says;
  silent on agency intent and enforcement practice. Bias: none
  identified.
- **MED Industry Bulletin 25-16** (2025-12-22; archived). Role: primary —
  the agency's own summary of the testing revisions. Used for: the entire
  "what changed" list and the July 1 solvent-panel effective date.
  Factuality: authoritative as the agency's characterization of its own
  rule changes; expressly not exhaustive ("does not encompass all new or
  revised rules"). Bias: official agency presentation of its own
  rulemaking.
- **MED Industry Bulletin 26-07** (2026-06-29; archived). Role: primary.
  Used for: the solvent-panel delay, the no-certified-lab statement, the
  certification-plus-72-hours enforcement trigger. Factuality:
  authoritative as of its date; says nothing about certifications after
  2026-06-29. Bias: official agency communication managing an
  implementation failure it attributes to lab readiness.
- **MED Industry Bulletin 26-01** (2026-01-23; archived). Role: primary.
  Used for: pesticide concentration during extraction, the
  retest-or-destroy pathways, observed dilution and R&D-testing
  circumvention practices, increased health-and-safety advisories.
  Factuality: authoritative for the Division's stated observations and
  enforcement position; its trend statements are the agency's
  characterization, not audited statistics. Bias: enforcement agency
  describing conduct it intends to act against.
- **MED rules page** (med.colorado.gov/rules; archived 2026-08-09). Role:
  primary — agency index. Used for: adoption date 2025-11-05 and
  effective date 2026-01-05. Factuality: authoritative for what MED
  posted as of retrieval. Bias: official agency presentation.
